home
Read about our high-engagement patient communities and care solutions
Related Articles
The trade-off between accelerated cancer drug approvals and patient preferences
Cancer care stands at a critical juncture where the urgency of rapid drug approvals must be balanced against the need for enduring patient-centric benefits. Robin…
Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The IMPROVE Trial | Journal of Clinical Oncology
PURPOSETo investigate whether intermittent treatment after an induction phase of first-line schedule of fluorouracil, leucovorin, and irinotecan (FOLFIRI) plus panitumumab (PAN) prevents or delays the…
Paper: Lack of Benefit of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts) in First Complete Remission (CR) with Undetectable Minimal Residual Disease (uMRD): Initial Report from the ECOG-ACRIN EA4151 Phase 3 Randomized Trial
Program: Late-breaking Abstracts Session: Late-Breaking Abstracts Session Hematology Disease Topics & Pathways: Research, Clinical trials, Lymphomas, Non-Hodgkin lymphoma, Clinical Research, B Cell lymphoma, Diseases, Lymphoid…
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution
Nature – Whole-genome sequencing of matched serial tumours from patients identifies two key mutagenic factors (APOBEC3 and chemotherapy) and extrachromosomal DNA-forming structural variants that…
Adobe Acrobat – THCA-report-_-Digging-deeper-going-further_-creating-health-in-communities-Final-Feb-2021.pdf
View this file, and add comments too.
🩺 Abordaje Moderno de la Pancreatitis Aguda en Emergencias 🚨
Explora el abordaje más actualizado y basado en evidencia para la pancreatitis aguda en emergencias 🚨🩺. Aprende sobre diagnóstico, manejo inicial y cuidado…
Inside your body, aging unfolds at remarkably different rates
New research shows aging is not a uniform process. Parts of our bodies start aging earlier than others, right down to our organs and cells.
Paper: Preliminary Safety and Tolerability of CD19x22 CAR-T Cell Therapy in Adolescent and Adult Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Program: Oral and Poster Abstracts Session: 628. Aggress ive Lymphomas: Cellular Therapies: Poster III 1 University of Colorado, Denver, CO 2 Division of Hematology, University…
Welcome! You are invited to join a webinar: IACH Transplant Academy- Diagnosis and Grading of Chronic GVHD. After registering, you will receive a confirmation email about joining the webinar.
Speaker: Steven Pavletic Dr. Pavletic is an expert in chronic graft-versus-host disease (cGVHD); his clinical studies focus on improving treatment for patients with cGVHD. He…
Welcome to Own Your Labs – Own Your Labs
Click Here to Get Started Hello everyone – welcome to Own Your Labs We’ve long been getting our blood testing a bit cheaper than most through…
